Concepedia

Publication | Open Access

Effects of fremanezumab in patients with chronic migraine and comorbid depression: Subgroup analysis of the randomized HALO CM study

DOIFull Paper Access

52

Citations

28

References

2021

Year

Richard B. Lipton, Joshua M. Cohen, Maja Galić, Michael J. Seminerio, Paul Yeung, Ernesto Aycardi, Marcelo E. Bigal, Kristen Bibeau, Dawn C. Buse
Headache The Journal of Head and Face Pain

Abstract

Fremanezumab demonstrated efficacy in the preventive treatment of CM and reduced headache impact in patients with comorbid depression.

References

YearCitations

Page 1